Generic medicine

Mometasone Furoate 0.1% w/w Cream

Reviewed educational reference: what Mometasone Furoate is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Mometasone Furoate
Strength
0.1% w/w
Dosage form
Cream
Drug class
Topical Corticosteroid

Related products

No reviewed products are currently published for this generic.

Mometasone Furoate 0.1% w/w Cream contains Mometasone Furoate, a potent synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It is primarily indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. By modulating the immune response at the site of application, Mometasone Furoate 0.1% w/w Cream effectively reduces redness, swelling, and itching associated with various skin conditions.

At a glance

Quick look

Mometasone Furoate 0.1% w/w Cream is a medium-potency topical corticosteroid containing Mometasone Furoate.

How it works

It reduces skin inflammation, redness, and itching by suppressing the local immune response.

Who it is for

It is used to treat various skin conditions like eczema, psoriasis, and dermatitis.

Uses it for
EczemaPsoriasisDermatitisPruritusSeborrheaInflammation

Uses of Mometasone Furoate

  • Atopic dermatitis and chronic eczema flare-ups
  • Psoriasis vulgaris of the body and limbs
  • Seborrheic dermatitis affecting the scalp or face
  • Allergic and irritant contact dermatitis
  • Pruritus from inflammatory skin disorders
  • Nummular and discoid eczema lesions
  • Localized inflammatory skin reactions

Benefits of Mometasone Furoate

Rapid Symptom Relief
The primary benefit of Mometasone Furoate 0.1% w/w Cream is its ability to quickly suppress the inflammatory cascade in the skin. Patients often notice a significant reduction in itching and burning sensations within the first few days of consistent application. This rapid action helps prevent secondary skin damage caused by scratching.

Convenient Once-Daily Dosing
Unlike many older topical steroids that require multiple daily applications, Mometasone Furoate 0.1% w/w Cream is typically effective with a once-daily regimen. This simplifies the treatment plan, improves patient adherence, and reduces the overall risk of systemic absorption associated with frequent, high-volume use.

Side effects of Mometasone Furoate

While generally well-tolerated, the use of Mometasone Furoate 0.1% w/w Cream can lead to localized adverse reactions, especially with prolonged use or when applied under occlusive dressings. Common side effects include a burning or stinging sensation at the application site, which is usually mild and transient. Some users may experience pruritus, skin atrophy, or the development of striae (stretch marks) in areas where the skin is thin, such as the face or skin folds. There is also a risk of developing acneiform eruptions, folliculitis, or hypopigmentation. In rare instances, systemic absorption can occur, potentially leading to hypothalamic-pituitary-adrenal (HPA) axis suppression, particularly in children or when large surface areas are treated for extended periods. If you notice signs of skin thinning, persistent redness, or unusual hair growth, discontinue use and consult your healthcare provider immediately.

Side effectHow commonHow severeWhat to do
Skin atrophyUncommonModerateLimit the duration of use to the minimum necessary.
Burning or stingingCommonMildApply a thinner layer of the cream.
TelangiectasiaUncommonModerateAvoid use on the face and thin skin areas.

How to manage side effects

Skin atrophy

  • Discontinue the medication.
  • Consult a dermatologist.
  • Allow the skin barrier to recover.

Burning or stinging

  • Monitor for persistent irritation.
  • Wash the area with cool water.
  • Seek advice if it does not resolve.

Telangiectasia

  • Discontinue use.
  • Consult a physician for alternative therapies.
  • Monitor for further skin changes.

How to use Mometasone Furoate

  • Wash and dry the affected area thoroughly before application.
  • Apply a thin film of Mometasone Furoate 0.1% w/w Cream to the affected skin areas once daily.
  • Gently rub the cream into the skin until it disappears completely.
  • Do not cover the treated area with bandages or airtight dressings unless directed by your doctor.
  • Wash your hands after application unless the hands are the area being treated.
  • Avoid contact with eyes, mouth, or open wounds.

Special population advice

Children

  • Use the minimum amount required.
  • Avoid use under diapers or plastic pants.
  • Limit treatment duration to avoid growth retardation.

Elderly

  • Monitor for skin atrophy.
  • Use with caution on thin or fragile skin.

Kidney impairment

  • No dose adjustment needed.

Liver impairment

  • No dose adjustment needed.

How Mometasone Furoate works

Mometasone Furoate works by inducing the production of lipocortins, which are proteins that inhibit the enzyme phospholipase A2. By blocking this enzyme, the drug prevents the release of arachidonic acid, a precursor to inflammatory mediators like prostaglandins and leukotrienes. This action reduces local inflammation, suppresses the immune response, and constricts small blood vessels in the skin.

What if you miss or exceed a dose?

If you miss a dose

If you forget to apply a dose of Mometasone Furoate 0.1% w/w Cream, apply it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed application and continue with your regular routine. Do not apply a double dose to make up for a missed one, as this increases the risk of local skin irritation.

In case of overdose

Topical overdose is unlikely to cause acute systemic toxicity. However, excessive or prolonged use of Mometasone Furoate 0.1% w/w Cream can lead to systemic effects such as HPA axis suppression, Cushing's syndrome, or hyperglycemia. If you suspect an overdose due to excessive application over a large area, wash the area thoroughly and seek medical advice. There is no specific antidote for topical steroid overdose.

AntidoteNo specific antidote exists.

Treatment is symptomatic and supportive.

Discontinuation
Stop the use of the medication immediately if signs of systemic toxicity appear.
Monitoring
Monitor for HPA axis suppression through clinical assessment.
Supportive Care
Manage electrolyte imbalances if systemic absorption is significant.
Follow-up
Consult a dermatologist for alternative treatment strategies.

Safety and precautions

When to avoid Mometasone Furoate

Do not take if you
  • Rosacea

    Topical steroids can exacerbate rosacea.

  • Perioral dermatitis

    May worsen the condition.

  • Bacterial/Fungal/Viral skin infections

    Steroids can mask or worsen untreated infections.

Use with caution
  • Thin skin areas

    Increased risk of atrophy in skin folds or face.

  • Large surface areas

    Higher risk of systemic absorption.

  • Occlusive dressings

    Increases potency and systemic absorption risk.

  • Children

    Higher surface-area-to-body-weight ratio increases systemic risk.

Safety at a glance

AlcoholSafe

Alcohol consumption does not directly interact with topical Mometasone Furoate.

PregnancyConsult your doctor

Use only if the potential benefit justifies the risk to the fetus. Consult your doctor.

BreastfeedingConsult your doctor

Consult your doctor before use. It is unknown if topical steroids pass into breast milk.

DrivingSafe

Topical application does not affect your ability to drive or operate machinery.

KidneySafe

No specific dose adjustment is required for patients with renal impairment.

LiverSafe

No specific dose adjustment is required for patients with hepatic impairment.

AllergyUnsafe

Do not use if you have a known hypersensitivity to Mometasone Furoate or any other ingredients in the cream.

ChildrenUse with caution

Use with extreme caution in children as they are more susceptible to systemic absorption.

ElderlySafe

No specific precautions are required, but monitor for skin thinning.

Interactions

With other medicines

Other topical corticosteroids

Moderate

Changes the medicine’s effect

What can happen: Increased risk of systemic absorption and local side effects.

What to do: Avoid concurrent use of multiple topical steroids.

Systemic corticosteroids

Moderate

Changes the medicine’s effect

What can happen: Additive risk of HPA axis suppression.

What to do: Monitor for signs of systemic corticosteroid excess.

Immunosuppressants

Minor

Changes the medicine’s effect

What can happen: Potential for increased risk of infection.

What to do: Monitor the skin for signs of secondary infection.

With food and drink

  • Grapefruit and grapefruit juiceMinor

    May theoretically affect hepatic metabolism if significant systemic absorption occurs.

  • High-sodium foodsMinor

    Caution advised if extensive systemic absorption leads to fluid retention tendencies.

If you have another condition

  • Diabetes

    Systemic absorption of corticosteroids may affect blood glucose control.

  • Cushing's Syndrome

    Topical steroids may worsen the condition if absorbed systemically.

Effect on laboratory tests

  • HPA axis function tests

    May show suppressed cortisol levels

    Systemic absorption can lead to false results in adrenal function tests.

Quick tips

  • Use the smallest amount of Mometasone Furoate 0.1% w/w Cream necessary to cover the affected area.
  • Avoid applying the cream to the face, groin, or underarms for more than a few days unless specifically instructed.
  • Monitor for signs of skin thinning or irritation during the course of treatment.
  • Do not share this medication with others, even if they have similar skin symptoms.
  • If your skin condition does not improve after two weeks of use, consult your doctor for a re-evaluation.
  • Store the tube tightly closed in a cool, dry place away from direct sunlight.

Counselling points

  • ApplicationImportant

    Apply only a thin layer and rub in gently.

  • DurationImportant

    Do not use for longer than prescribed by your doctor.

  • OcclusionImportant

    Do not cover the area with bandages unless told to do so.

  • HygieneGood to know

    Wash hands after application to avoid accidental contact with eyes.

Monitoring during treatment

Before starting

  • Skin assessment of the affected area
  • Blood pressure check if long-term use is planned

During treatment

  • every 4 weeks: Assess for skin atrophy or striae

What is being watched

  • Skin integrity
  • Signs of secondary infection
  • HPA axis function if systemic symptoms arise

Pharmacokinetics

Absorption
Minimal percutaneous absorption; increased by occlusion or damaged skin.
Bioavailability
Low systemic bioavailability.
Protein binding
Approximately 98-99%.
Volume of distribution
Not established.
Half-life
Not established for topical use.
Metabolism
Primarily metabolized in the liver.
Excretion
Excreted via bile and urine.
Onset / duration
Onset within hours; duration of action is 24 hours.

Fact box

Chemical class
Synthetic Glucocorticoid
Habit forming
No
Therapeutic class
Anti-inflammatory and Antipruritic Agent
Action class
Medium-potency Topical Corticosteroid
Storage
Store at room temperature (20°C to 25°C). Keep the tube tightly closed. Do not freeze. Keep out of reach of children.
ATC code
D07AC13
Pregnancy category
C

More information

Clinical Rationale for Mometasone Furoate

Clinicians frequently select Mometasone Furoate as a first-line treatment for inflammatory dermatoses due to its favorable balance between efficacy and safety. As a medium-potency corticosteroid, it provides a robust anti-inflammatory effect that is superior to low-potency agents like hydrocortisone, yet it carries a lower risk profile for skin atrophy compared to high-potency agents like clobetasol. This makes it an ideal choice for managing conditions like eczema and psoriasis where sustained control is required without the immediate risk of severe side effects. The once-daily dosing regimen is a critical factor in clinical practice, as it significantly improves patient compliance compared to twice-daily alternatives, leading to better overall treatment outcomes in chronic skin conditions.

Comparison with Alternative Treatments

When comparing Mometasone Furoate 0.1% w/w Cream to other topical treatments, the primary differentiator is its potency classification and its pharmacokinetic profile. While hydrocortisone is safer for sensitive areas like the face or skin folds, it often lacks the potency required to manage moderate to severe flares of psoriasis or contact dermatitis. Conversely, ultra-high-potency steroids are effective but carry a high risk of permanent skin thinning, telangiectasia, and systemic absorption if used for more than two weeks. Mometasone Furoate occupies a middle ground, offering sufficient potency to resolve active inflammation while remaining safer for longer durations than ultra-high-potency agents. It is often preferred over non-steroidal topical calcineurin inhibitors for initial flare management due to its faster onset of action and lower cost, although calcineurin inhibitors remain useful for maintenance therapy in sensitive areas.

Lifestyle and Skin Care During Treatment

Managing skin conditions involves more than just applying medication. While using Mometasone Furoate 0.1% w/w Cream, it is essential to maintain a consistent skincare routine. Use mild, fragrance-free cleansers to avoid further irritation of the skin barrier. Moisturizing is vital; apply a bland emollient or moisturizer at least 30 minutes before or after applying the medicated cream to ensure the skin remains hydrated. Avoid triggers such as harsh soaps, synthetic fabrics, or extreme temperatures that can exacerbate itching. If you are treating psoriasis, avoid picking at scales, as this can lead to the Koebner phenomenon, where new lesions form at the site of skin trauma. Maintaining a healthy diet and managing stress can also help reduce the frequency of inflammatory flares, as stress is a known trigger for many dermatological conditions.

Common Misconceptions and Safety

A common misconception is that all topical steroids are equally dangerous or that they should be avoided entirely. While systemic side effects are a theoretical risk, they are extremely rare when Mometasone Furoate 0.1% w/w Cream is used correctly on limited surface areas. Another misconception is that the cream can be used to treat any skin rash; this is dangerous because applying a steroid to an undiagnosed fungal or bacterial infection can mask the symptoms and allow the infection to spread unchecked. Always ensure a proper diagnosis from a healthcare professional before starting treatment. Finally, patients often fear that stopping the medication will cause an immediate rebound flare. While this can happen if the underlying condition is not fully controlled, it is not a reason to continue the medication indefinitely. Tapering the frequency of application under medical guidance is the standard approach to prevent rebound symptoms.

References

  1. Medicines and Healthcare products Regulatory Agency. Mometasone Furoate 0.1% Cream, Summary of Product Characteristics.View sourceAccessed
  2. Pharmacy and Poisons Board Kenya. Natcort Cream, Summary of Product Characteristics.View sourceAccessed
  3. US Food and Drug Administration. Mometasone Furoate Cream label.View sourceAccessed
  4. Medical Products Agency Sweden. Ovixan Cream, Summary of Product Characteristics.View sourceAccessed
  5. DailyMed, US National Library of Medicine. Mometasone Furoate Cream label.View sourceAccessed
  6. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Mometasone Furoate

Can I use Mometasone Furoate 0.1% w/w Cream on my face?

Only use Mometasone Furoate 0.1% w/w Cream on the face if specifically directed by your doctor, as the skin on the face is thin and prone to side effects like atrophy.

How long can I use Mometasone Furoate 0.1% w/w Cream?

Use the medication for the shortest duration necessary to control symptoms. Avoid continuous long-term use without medical supervision.

Does Mometasone Furoate 0.1% w/w Cream cause skin thinning?

Yes, prolonged use of any topical corticosteroid can lead to skin thinning. Always follow the prescribed duration of treatment.

What should I do if my skin condition worsens?

Stop using the cream and consult your doctor, as the condition may require a different type of treatment, such as an antifungal or antibiotic.

Is Mometasone Furoate 0.1% w/w Cream a steroid?

Yes, Mometasone Furoate 0.1% w/w Cream is a synthetic corticosteroid used to reduce inflammation and itching.

Latest